Apple Watch Detects AFib 4x More Than Standard Clinical Monitoring

A study from Amsterdam UMC found that Apple Watch detected atrial fibrillation in 10% of at-risk patients, compared to just 2% caught by traditional monitoring methods. That is a significant gap, and for endurance athletes who already sit in an elevated AFib risk category due to high training volumes, it matters.

Most of the detected cases were asymptomatic, meaning athletes had no idea anything was off. This is exactly the scenario where a wrist-worn ECG sensor earns its keep. You are not going to feel a thing during a long run, but your watch might catch something your cardiologist missed at your annual checkup.

Apple Watch Series 4 and later carry an FDA-cleared single-lead ECG app, the same core feature here. Garmin and Polar have added AFib detection to their flagship devices too, and Withings has leaned hard into clinical-grade heart monitoring. But Apple's ecosystem and the volume of users wearing it daily gives researchers a dataset no sports watch brand can match yet.

For triathletes, cyclists, and runners logging serious weekly hours, this is a real use case, not a marketing bullet point. Chronic endurance training is linked to structural cardiac changes that raise AFib risk. Having passive, continuous screening on your wrist during daily life and recovery adds a layer of monitoring that a 10-minute ECG strip at a clinic simply cannot replicate.

The verdict: Apple Watch is not a medical device replacement, but this data makes a strong case for wearing one if AFib risk is on your radar. Four times the detection rate is not a rounding error.